E-DRUG: RFI: Price of Glivec in India, China, Philippines (2)
------------------------------------------------------------
[3 messages in 1; thanks E-druggers for the info! Generic imatinib is 8x
cheaper than branded. A candidate for a compulsory license procedure in
countries with patent protection? See
http://www.cptech.org/ip/health/gleevec/ for much more info on the Glivec
price debate. WB]
Glivec brand of imatinib is not marketed in India. A
generic version sold by Ranbaxy Laboratories Ltd.
under the brand name of Zoleta costs Indian Rs. 1000
(US$ 22.50) for 10 tablets.
Dr. Chandra M. Gulhati
Editor, MIMS INDIA
(Monthly Index of Medical Specialities)
503 Mansarovar,
90 Nehru Place,
New Delhi 110019.
Tel: 26433115
Fax: 26424016/26463720
----------
[another message from India says Glivec is available, but at 8x the cost of
the generic; WB]
Message from: rajeshwari@knspartners.com
the price of glivec in India is rs1200/- per capsule [USD 2.70; WB]
----------
Dear Julien Reinhard,
According to Philippines Index of Medical Specialties of 4th
quarter of 2003 which is the latest edition Glivec has 100mg x
120's is PhP 151,253.96 which is about $22.50 each or $2700.00
for the total box. This is a purchase price to the company only.
-------------
[old IP-Health message; see
http://www.cptech.org/ip/health/gleevec/gleevecprice-korea01222003.html\]
Note on Glivec Price Hike in South Korea
January 22, 2003
Today, South Korea government decided to raise the price of Glivec by about
30%.
On 16th November 2001 SK government set the ceiling price of Glivec KRW
17,862 per 100 mg capsule (about USD 15). However, Novartis denied to accept
the price and applied for the price adjustment with arguing that the price
should be raised by 34%. Novartis said its price was based on the average
price of Glivec in seven advanced countries - France, Switzerland, Italy,
Germany, Canada, the UK and the US. Accepting most of the Novartis'
positions, SK government adjusted the price to be KRW 23,045 (about USD
19.2) that corresponds to 83% of the average price of A7 prices.
With the price advance, previous 30% of cost share by patients was lowered
to 20%.
By the decision of today, the cost paid by a leukemia patient ranges from
KRW 497,772 to 1,244,430 (about USD 415 to 1,037) per month.
HeeSeob Nam
Patent Attorney, Intellectual Property Left
Dabong Tower Bldg., 10th Fl.,
890-12 Daechi-dong
Kangnam-gu, Seoul, Korea 135-280
Tel. +82 2 3430 4300 Fax. +82 2 3430 4200
E-mail: heeseob_n@yahoo.co.kr
---------
[If any e-drugger still has more info, please send directly to
reinhard@ladb.ch Thanks WB]
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug